BioNTech AG announced that it has received $270,000,000 (€230,000,000) in its series A round of funding led by new investor Redmile Group, LLC on January 4, 2018. The transaction also included participation from new investors The Invus Group, LLC, Fidelity Management & Research Company, Janus Henderson Investors, several European family offices, and existing investor Struengmann Family Office. The company issued equity securities in the transaction. The company has raised $950,000,000 (€789,548,000) in funding till date.